The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New leadership moves, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Leadership Trends
See who's moving and how much in your market
No credit card required Weekly executive digest
Teva Pharmaceutical Industries Ltd. Appoints Matthew Shields As Executive Vice President of Teva Global Operations
PRIVATEMay 15, 2024•about 2 years ago
Position
Executive Vice President
Company
Teva
Matthew Shields
Tel AvivManufacturingBiotechnologyHealth CarePharmaceutical
Description
Teva Pharmaceutical Industries Ltd. has appointed Matthew Shields as the Executive Vice President of Teva Global Operations (TGO), effective from June 3, 2024
Company Information
Company
Teva
Location
Tel Aviv, Tel Aviv District, Israel
About
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has been developing and producing medicines to improve people’s lives for more than a century. We are a global leader in generic and innovative medicines with a portfolio consisting of over 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day, and are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative medicines research and operations supporting our growing portfolio of innovative medicines and biopharmaceutical products.